Department of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, PR China.
Research Institute of Nephrology, Zhengzhou University, Zhengzhou, 450052, PR China.
Cell Death Dis. 2021 Mar 10;12(3):255. doi: 10.1038/s41419-021-03460-x.
Diabetic nephropathy (DN) is a serious complication in type 1 and type 2 diabetes, and renal interstitial fibrosis plays a key role in DN progression. Here, we aimed to probe into the role and potential mechanism of miR-483-5p in DN-induced renal interstitial fibrosis. In this study, we corroborated that miR-483-5p expression was lessened in type 1 and type 2 diabetic mice kidney tissues and high glucose (HG)-stimulated tubular epithelial cells (TECs), and raised in the exosomes derived from renal tissues in type 1 and type 2 diabetic mice. miR-483-5p restrained the expressions of fibrosis-related genes in vitro and renal interstitial fibrosis in vivo. Mechanistically, miR-483-5p bound both TIMP2 and MAPK1, and TIMP2 and MAPK1 were bound up with the regulation of miR-483-5p on renal TECs under HG conditions. Importantly, HNRNPA1-mediated exosomal sorting transported cellular miR-483-5p out of TECs into the urine. Our results expounded that HNRNPA1-mediated exosomal sorting transported cellular miR-483-5p out of TECs into the urine, thus lessening the restraint of cellular miR-483-5p on MAPK1 and TIMP2 mRNAs, and ultimately boosting extracellular matrix deposition and the progression of DN-induced renal interstitial fibrosis.
糖尿病肾病 (DN) 是 1 型和 2 型糖尿病的严重并发症,肾间质纤维化在 DN 进展中起着关键作用。在这里,我们旨在探讨 miR-483-5p 在 DN 诱导的肾间质纤维化中的作用和潜在机制。在这项研究中,我们证实 miR-483-5p 在 1 型和 2 型糖尿病小鼠肾脏组织和高糖 (HG) 刺激的肾小管上皮细胞 (TEC) 中的表达减少,而在 1 型和 2 型糖尿病小鼠肾脏组织来源的外泌体中表达增加。miR-483-5p 在体外抑制纤维化相关基因的表达,并在体内抑制肾间质纤维化。机制上,miR-483-5p 结合 TIMP2 和 MAPK1,而 TIMP2 和 MAPK1 与 miR-483-5p 在 HG 条件下对肾 TEC 的调节有关。重要的是,HNRNPA1 介导的外泌体分选将细胞内 miR-483-5p 从 TEC 中运出到尿液中。我们的结果表明,HNRNPA1 介导的外泌体分选将细胞内 miR-483-5p 从 TEC 中运出到尿液中,从而减轻了细胞内 miR-483-5p 对 MAPK1 和 TIMP2 mRNA 的抑制作用,最终促进细胞外基质沉积和 DN 诱导的肾间质纤维化的进展。